Breaking New Film ‘The End of Oak Street’ Delivers Gonzo Thrills with a Dinosaur Twist Steelers’ Preseason Opener Features Homecoming Narratives Paris Saint-Germain Kicks Off Season in UEFA Super Cup Amidst Ambitious Trophy Hunt Key 2026 College Football Matchups Poised to Shape Playoff Picture New York City’s “Pied-à-terre” Tax Sparks Debate and Legal Challenges

Wednesday August 12, 2026

Section

Time Sensitive

National - Breaking

Bill Oddie, Comedian and Wildlife Presenter, Dies at 85

SignalNewsAI · Jul 27

Press Release

Costamare Inc. Reports Results for the Second Quarter and Six-Month Period Ended June 30, 2026

Costamare Inc · Jul 27

Press Release

Dr. Max Lataillade to Participate in Four Scientific Sessions at IAS 2026 Focused on the Future of Long-Acting HIV Prevention and Treatment

Dr. Max Lataillade · Jul 27

Press Release

HyProMag USA to Establish Early Magnet Finishing Capability as Part of Phased Texas Hub Development

CoTec Holdings Corp. · Jul 27

Press Release

Black Book Expands Vendor-Agnostic Healthcare Supply Chain Technology Benchmark to 36 Categories for AHRMM26

Black Book Research · Jul 27

Press Release

TaxBandits Supports Employers and Tax Professionals in Filing Form 941 and State Payroll Returns Before July 31

TaxBandits · Jul 27

Press Release

TransDigm Announces Acquisition of Prince & Izant

TransDigm Group Inc. · Jul 27

Press Release

Domino’s® Serves Up Summer Savings: All Menu-Priced Pizzas Are 50% Off July 27-Aug. 2

Domino's Pizza · Jul 27

Press Release

GCT Semiconductor Holding, Inc. to Give Business Update and Announce Second Quarter 2026 Financial Results on August 10, 2026

Business Wire · Jul 27

Press Release

Sharon AI to Announce Second Quarter 2026 Results

Sharon AI Holdings Inc. · Jul 27

Press Release

Oklo Announces Date for Second Quarter 2026 Financial Results and Business Update Call

Business Wire · Jul 27

Press Release

Boost Run Announces Warrant Redemption

Business Wire · Jul 27

Press Release

Yarrow Bioscience Announces Closing of Merger with VYNE Therapeutics and Initiation of Dosing in Phase 2a/2b Trial of YB-101, a Potential First-in-Class Treatment for Graves’ Disease and Thyroid Eye Disease

Business Wire · Jul 27

← Previous 1 … 662 663 664 … 718 Next →